This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 26/6/1370    most recent 01.ATV.0000217910.90210.99v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nishiwaki, M. Articles by Brewer, H. B. Search for Related Content PubMed PubMed Citation Articles by Nishiwaki, M. Articles by Brewer, H. B., Jr Related Collections Related Article

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1370.)
© 2006 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Human Lecithin:Cholesterol Acyltransferase Deficiency

In Vivo Kinetics of Low-Density Lipoprotein and Lipoprotein-X

Masato Nishiwaki; Katsunori Ikewaki; Giovanni Bader; Hassan Nazih; Minna Hannuksela; Alan T. Remaley; Robert D. Shamburek; H. Bryan Brewer, Jr

From the Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md. Current affiliation for M.N.: First Department of Internal Medicine, National Defense Medical College, Saitama, Japan. Current affiliation for K.I.: Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.

Correspondence to Dr M. Nishiwaki, First Department of Internal Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513 Japan. E-mail masato{at}hi-ho.ne.jp

Objectives— Lecithin:cholesterol acyltransferase deficiency (LCAT-def) is characterized by low levels of high-density lipoprotein (HDL) and low-density lipoprotein (LDL) and the accumulation of lipoprotein-X (LpX). Despite the low HDL, atherosclerosis is uncommon in LCAT-def. The decreased LDL would be a possible explanation but the underlying mechanism is not clear. In addition, the mechanism(s) for LpX accumulation is not known. The aim of the present study is to elucidate the mechanism(s) responsible for the low LDL and determine the plasma kinetics of LpX in LCAT-def.

Methods and Results— We conducted a radiotracer study in LCAT-def (n=2) and normal controls (n=10) and a stable isotope study in one patient and other controls (n=7). LCAT-def LDL was catabolized faster than control LDL in the control subjects as well as in LCAT-def patients. Control LDL was catabolized faster in LCAT-def patients than the controls. The production rate of LDL apolipoprotein B-100 was normal in LCAT-def. The increased LDL apoB-100 catabolism was confirmed by a stable isotope study. LpX was catabolized more slowly in LCAT-def.

Conclusions— The decreased LDL in LCAT-def is attributable to an increased catabolism caused by a rapid catabolism of abnormal LDL and an upregulation of LDL receptor pathway. The decreased catabolism of LpX contributes to its accumulation in LCAT-def.

To elucidate the mechanism(s) responsible for the low LDL level in LCAT deficiency (LCAT-def), kinetic studies using radiotracers and a stable isotope were conducted in LCAT-def. Both studies revealed an increased catabolism of LDL. In addition, the radiotracer study showed a decreased catabolism of LpX in LCAT-def.

Key Words: lecithin:cholesterol acyltransferase • low-density lipoprotein • lipoprotein-X • kinetics • stable isotope

Related Article:

Lipoprotein Metabolism: A Well-Tried Tool to Characterize Dyslipidemic Mechanisms

Lars Berglund
Arterioscler. Thromb. Vasc. Biol. 2006 26: 1201-1203. [Full Text] [PDF]

This article has been cited by other articles:

				V. Charlton-Menys, L. Pisciotta, P. N. Durrington, R. Neary, C. D. Short, L. Calabresi, S. Calandra, and S. Bertolini Molecular characterization of two patients with severe LCAT deficiency Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2379 - 2382. [Full Text] [PDF]

				L. Berglund Lipoprotein Metabolism: A Well-Tried Tool to Characterize Dyslipidemic Mechanisms. Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1201 - 1203. [Full Text] [PDF]